Nicotine-Targeting Nano-Vaccines for Smoking Cessation.
作者信息
Desai Rajeev I, Bergman Jack
机构信息
Preclinical Pharmacology Laboratory (RID, JB), McLean Hospital/Harvard Medical School, Belmont, MA, USA.
出版信息
Neuropsychopharmacology. 2016 Jan;41(1):377-8. doi: 10.1038/npp.2015.234.
Abstract
摘要
相似文献
1
Nicotine-Targeting Nano-Vaccines for Smoking Cessation.
Neuropsychopharmacology. 2016 Jan;41(1):377-8. doi: 10.1038/npp.2015.234.
2
Nicotine conjugate vaccines: A novel approach in smoking cessation.
J Am Pharm Assoc (2003). 2012 Jan-Feb;52(1):116-8. doi: 10.1331/JAPhA.2012.12505.
3
[Immune to nicotine addiction?].
MMW Fortschr Med. 2013 Mar 21;155(5):22-3. doi: 10.1007/s15006-013-0267-8.
4
A shot at quitting.
Minn Med. 2006 Sep;89(9):9-10.
5
Could a novel vaccine help smokers quit?
JAMA. 2005 Aug 24;294(8):891-2. doi: 10.1001/jama.294.8.891.
6
Therapeutic vaccines for nicotine dependence.
Curr Opin Mol Ther. 2006 Feb;8(1):11-6.
7
Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines.
Biomaterials. 2018 Nov;182:72-81. doi: 10.1016/j.biomaterials.2018.08.015. Epub 2018 Aug 7.
8
Cytisine versus nicotine for smoking cessation.
N Engl J Med. 2015 Mar 12;372(11):1072. doi: 10.1056/NEJMc1500342.
9
[Recent progress in vaccines against nicotine addiction].
Yao Xue Xue Bao. 2013 Aug;48(8):1189-94.
10
Cytisine is more effective than nicotine replacement for smoking cessation.
Evid Based Med. 2015 Aug;20(4):130. doi: 10.1136/ebmed-2015-110188. Epub 2015 May 2.
引用本文的文献
1
New medications development for smoking cessation.
Addict Neurosci. 2023 Sep;7. doi: 10.1016/j.addicn.2023.100103. Epub 2023 May 18.
2
Dose-Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light-Dark Test in Mice.
Dose Response. 2018 Jun 26;16(2):1559325818779752. doi: 10.1177/1559325818779752. eCollection 2018 Apr-Jun.
3
Are therapeutic vaccines an answer to the global problem of drug and alcohol abuse?
Indian J Pharmacol. 2016 Sep-Oct;48(5):487-489. doi: 10.4103/0253-7613.190717.
4
Biologics to treat substance use disorders: Current status and new directions.
Hum Vaccin Immunother. 2016 Dec;12(12):3005-3019. doi: 10.1080/21645515.2016.1212785. Epub 2016 Jul 21.
本文引用的文献
1
Effects of the Nanoparticle-Based Vaccine, SEL-068, on Nicotine Discrimination in Squirrel Monkeys.
Neuropsychopharmacology. 2015 Aug;40(9):2207-16. doi: 10.1038/npp.2015.64. Epub 2015 Mar 6.
2
Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates.
Vaccine. 2014 May 19;32(24):2896-903. doi: 10.1016/j.vaccine.2014.02.024. Epub 2014 Feb 26.
3
New directions in nicotine vaccine design and use.
Adv Pharmacol. 2014;69:553-80. doi: 10.1016/B978-0-12-420118-7.00014-7.
4
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.
Clin Pharmacol Ther. 2011 Mar;89(3):392-9. doi: 10.1038/clpt.2010.317. Epub 2011 Jan 26.
5
Nicotine addiction.
N Engl J Med. 2010 Jun 17;362(24):2295-303. doi: 10.1056/NEJMra0809890.
6
Recognising nicotine: the neurobiological basis of nicotine discrimination.
Handb Exp Pharmacol. 2009(192):295-333. doi: 10.1007/978-3-540-69248-5_11.
Zotero 插件